A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Live Conference Call and Webcast TODAY at 4:30 p.m. ETENGLEWOOD, Colo., Feb. 16, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on developing treatments for urological and related conditions, provided today an overview of its...
Live Conference Call and Webcast Scheduled for February 16, 2016, at 4:30 p.m. ETENGLEWOOD, Colo., Feb. 11, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on developing treatments for urological and related conditions, announced...
ENGLEWOOD, Colo., Feb. 9, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on commercializing treatments for urological conditions, today announced the first commercial sales of its MiOXSYS™ System in Europe...
ENGLEWOOD, Colo., Feb. 3, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on urological and related conditions, announced today that the Company will present at Source Capital Group's 2016 Disruptive Growth &...
ENGLEWOOD, Co., Jan. 27, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on commercializing treatments for urological and related conditions, today announced that Josh Disbrow, Aytu's Chief Executive Officer, and Jarrett Disbrow,...
Regulatory Clearance Enables Commercialization in Europe and other Key MarketsENGLEWOOD, Colo., Jan. 12, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on commercializing treatments for urological and related conditions, today...
ENGLEWOOD, Colo., Jan. 6, 2016 -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on urological and related conditions, announced today that the Company will present at the Biotech Showcase™ 2016, taking place in San...